These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2479375)

  • 1. Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo.
    Reilly TM; Taylor DS; Herblin WF; Thoolen MJ; Chiu AT; Watson DW; Timmermans PB
    Biochem Biophys Res Commun; 1989 Oct; 164(2):736-43. PubMed ID: 2479375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis.
    Matsuzaki K; Yoshitake Y; Matuo Y; Sasaki H; Nishikawa K
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9911-5. PubMed ID: 2481318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of modulation of basic fibroblast growth factor on tumor growth in vivo.
    Gross JL; Herblin WF; Dusak BA; Czerniak P; Diamond MD; Sun T; Eidsvoog K; Dexter DL; Yayon A
    J Natl Cancer Inst; 1993 Jan; 85(2):121-31. PubMed ID: 8418301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line.
    Morrison RS; Gross JL; Herblin WF; Reilly TM; LaSala PA; Alterman RL; Moskal JR; Kornblith PL; Dexter DL
    Cancer Res; 1990 Apr; 50(8):2524-9. PubMed ID: 2156622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibodies inhibit the binding of basic fibroblast growth factor to its receptor but not to heparin.
    Kurokawa M; Doctrow SR; Klagsbrun M
    J Biol Chem; 1989 May; 264(13):7686-91. PubMed ID: 2540201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High affinity binding sites for basic fibroblast growth factor in rat hepatic plasma membranes.
    Gauthier T; Herbert JJ; Maftoun M; Picard C; Morre M
    Life Sci; 1989; 44(8):509-16. PubMed ID: 2564619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different antitumor activities of anti-bFGF neutralizing antibodies: heparin-binding domain provides an inefficient epitope for neutralization in vivo.
    Aonuma M; Yoshitake Y; Nishikawa K; Tanaka NG
    Anticancer Res; 1999; 19(5B):4039-44. PubMed ID: 10628351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylation of the basic fibroblast growth factor receptor. The contribution of carbohydrate to receptor function.
    Feige JJ; Baird A
    J Biol Chem; 1988 Oct; 263(28):14023-9. PubMed ID: 2844752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of basic fibroblast growth factor (bFGF) in a metastatic cell line (AT-3) established from the Dunning prostatic carcinoma of rat: application of a specific monoclonal antibody.
    Nishikawa K; Yoshitake Y; Minemura M; Yamada K; Matuo Y
    Adv Exp Med Biol; 1992; 324():131-9. PubMed ID: 1283495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appearance of basic fibroblast growth factor receptors upon differentiation of rat mammary epithelial to myoepithelial-like cells in culture.
    Fernig DG; Smith JA; Rudland PS
    J Cell Physiol; 1990 Jan; 142(1):108-16. PubMed ID: 2153686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library.
    Yayon A; Aviezer D; Safran M; Gross JL; Heldman Y; Cabilly S; Givol D; Katchalski-Katzir E
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10643-7. PubMed ID: 7504274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat mammary myoepithelial-like cells in culture possess kinetically distinct low-affinity receptors for fibroblast growth factor that modulate growth stimulatory responses.
    Fernig DG; Rudland PS; Smith JA
    Growth Factors; 1992; 7(1):27-39. PubMed ID: 1323979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin.
    Yayon A; Klagsbrun M
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5346-50. PubMed ID: 2164679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic fibroblast growth factor production and growth factor receptors as potential targets for melanoma therapy.
    Kato J; Wanebo H; Calabresi P; Clark JW
    Melanoma Res; 1992 May; 2(1):13-23. PubMed ID: 1322754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region.
    Presta M; Statuto M; Isacchi A; Caccia P; Pozzi A; Gualandris A; Rusnati M; Bergonzoni L; Sarmientos P
    Biochem Biophys Res Commun; 1992 Jun; 185(3):1098-107. PubMed ID: 1378264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a Mr 25,000 basic fibroblast growth factor form in adult, regenerating, and fetal rat liver.
    Presta M; Statuto M; Rusnati M; Dell'Era P; Ragnotti G
    Biochem Biophys Res Commun; 1989 Nov; 164(3):1182-9. PubMed ID: 2556120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of a quantitative RIA for basic fibroblast growth factor using polyclonal antibodies against the 157 amino acid form of human bFGF. The identification of bFGF in adherent elicited murine peritoneal macrophages.
    Joseph-Silverstein J; Moscatelli D; Rifkin DB
    J Immunol Methods; 1988 Jun; 110(2):183-92. PubMed ID: 3379311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Culture-induced increase in acidic and basic fibroblast growth factor activities and their association with the nuclei of vascular endothelial and smooth muscle cells.
    Speir E; Sasse J; Shrivastav S; Casscells W
    J Cell Physiol; 1991 May; 147(2):362-73. PubMed ID: 1710230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin.
    Moscatelli D; Quarto N
    J Cell Biol; 1989 Nov; 109(5):2519-27. PubMed ID: 2553749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells.
    Moscatelli D
    J Cell Biol; 1988 Aug; 107(2):753-9. PubMed ID: 2843546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.